St. Mary's Hospital is a private, non-for-profit hospital in the west end of Richmond, Virginia. It is a 391-bed hospital and serves the Central Virginia community and beyond. St. Mary's is affiliated with the Bon Secours Richmond Health System and the Sisters of Bon Secours.

There are 391 beds in Bon Secours Saint Mary's Hospital.

During the past decade, Bon Secours Saint Mary's Hospital conducted 76 clinical trials. In the 10-year time frame, 76 clinical trials started and 45 clinical trials were completed, i.e. on average, 59.2% percent of trials that started reached the finish line to date. In the past 5 years, 25 clinical trials started and 34 clinical trials were completed. i.e. 136% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Bon Secours Saint Mary's Hospital" #1 sponsor was "Radiation Therapy Oncology Group" with 22 trials, followed by "National Cancer Institute (NCI)" with 21 trials sponsored, "SWOG Cancer Research Network" with 19 trials sponsored, "Alliance for Clinical Trials in Oncology" with 12 trials sponsored and "Gilead Sciences" with 12 trials sponsored. Other sponsors include 36 different institutions and companies that sponsored additional 30 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bon Secours Saint Mary's Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 64 trials as a collaborator, "Canadian Cancer Trials Group" with 6 trials as a collaborator, "NRG Oncology" with 5 trials as a collaborator, "Medical University of South Carolina" with 3 trials as a collaborator and "North Central Cancer Treatment Group" with 2 trials as a collaborator. Other collaborators include 28 different institutions and companies that were collaborators in the rest 37 trials.

According to Clinical.Site data, the most researched conditions in "Bon Secours Saint Mary's Hospital" are "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Anatomic Stage II Breast Cancer AJCC v8" (6 trials), "Head and Neck Cancer" (6 trials) and "Prognostic Stage II Breast Cancer AJCC v8" (6 trials). Many other conditions were trialed in "Bon Secours Saint Mary's Hospital" in a lesser frequency.

Most popular intervention types in "Bon Secours Saint Mary's Hospital" are "Drug" (88 trials), "Other" (51 trials), "Procedure" (33 trials), "Biological" (32 trials) and "Radiation" (27 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (23 trials), "Quality-of-Life Assessment" (21 trials), "Questionnaire Administration" (18 trials), "Laboratory Biomarker Analysis" (17 trials) and "Placebo" (15 trials). Other intervention names were less common.

The vast majority of trials in "Bon Secours Saint Mary's Hospital" are 105 trials for "All" genders, 13 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Bon Secours Saint Mary's Hospital". undefined are not yet recruiting, 18 are recruiting, 37 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 58 completed trials in Bon Secours Saint Mary's Hospital, 1 suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Bon Secours Saint Mary's Hospital, 5 "Phase 1" clinical trials were conducted, 55 "Phase 2" clinical trials and 56 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 8 trials that are defined as “Not Applicable".